OB/GYN Clinical Alert – June 1, 2006
June 1, 2006
View Issues
-
Results of Raloxifene RUTH and STAR Trials
The Eli Lilly Company and the National Cancer Institute released preliminary results from two large clinical trials involving raloxifene. The Raloxifene Use for the Heart (RUTH) study included more than 10,000 women from 26 countries, either at high risk for myocardial infarction or with known coronary heart disease. -
Calorie Restriction on Biomarkers of Longevity, Metabolic Adaptation, and Oxidative Stress in Overweight Individuals
The aim of the present study was to determine if prolonged calorie restriction in humans would impact biomarkers of aging and oxidative stress. -
Membrane Sweeping at Initiation of Labor Induction
Tan et al randomized 264 women scheduled for induction to either have membrane swept (136) or to not have this done (128) prior to induction. If the cervix allowed the introduction of a finger, the membranes were swept once clockwise and once counter clockwise as high as possible. -
Angiogenesis and the Strategic Target for Ovarian Cancer Therapy
Angiogenesis is a necessary and crucial aspect of physiologic homeostasis. Under normal circumstances the processes and factors regulating new blood vessel formation are tightly controlled. -
Pharmacology Watch: Gastric Acid Secretion and the Absorption of Thyroxine
Can Plavix Add to the Efficacy of Aspirin?; Prevention of Hypertension?; Estrogen Alternatives; FDA Actions -
Clinical Briefs in Primary Care supplement